A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT05219721 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Multiple Myeloma
Plasma Cell Leukemia

Interventions

DRUG: CAR-T (CAR-GPRC5D)

Sponsor

Chunrui Li

Collaborators

[object Object]